Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2018 (2018), Article ID 2164312, 5 pages
https://doi.org/10.1155/2018/2164312
Case Report

Effect of Adalimumab on Refractory Arthritis in Juvenile Idiopathic Inflammatory Myopathy with Anti-MDA5 Autoantibody

1Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
2Department of Pediatrics, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan

Correspondence should be addressed to Takako Miyamae

Received 1 September 2017; Revised 12 November 2017; Accepted 28 November 2017; Published 6 February 2018

Academic Editor: Mehmet Soy

Copyright © 2018 Takako Miyamae et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Takako Miyamae, Takuma Hara, Aki Hanaya, Yumi Tani, Takayuki Kishi, and Hisashi Yamanaka, “Effect of Adalimumab on Refractory Arthritis in Juvenile Idiopathic Inflammatory Myopathy with Anti-MDA5 Autoantibody,” Case Reports in Rheumatology, vol. 2018, Article ID 2164312, 5 pages, 2018. doi:10.1155/2018/2164312